Literature DB >> 28784929

Type Three Secretion System-Dependent Microvascular Thrombosis and Ischemic Enteritis in Human Gut Xenografts Infected with Enteropathogenic Escherichia coli.

Einat Nissim-Eliraz1, Eilam Nir1, Irit Shoval1, Noga Marsiano1, Israel Nissan1, Hadar Shemesh1, Nandor Nagy2,3, Allan M Goldstein2, Michael Gutnick1, Ilan Rosenshine4, Simcha Yagel5, Nahum Y Shpigel6.   

Abstract

Enteropathogenic Escherichia coli (EPEC) is a leading cause of severe intestinal disease and infant mortality in developing countries. Virulence is mediated by a type three secretion system (T3SS), causing the hallmark attaching and effacing (AE) lesions and actin-rich pedestal formation beneath the infecting bacteria on the apical surface of enterocytes. EPEC is a human-specific pathogen whose pathogenesis cannot be studied in animal models. We therefore established an EPEC infection model in human gut xenografts in SCID mice and used it to study the role of T3SS in the pathogenesis of the disease. Following EPEC O127:H6 strain E2348/69 infection, T3SS-dependent AE lesions and pedestals were demonstrated in all infected xenografts. We report here the development of T3SS-dependent intestinal thrombotic microangiopathy (iTMA) and ischemic enteritis in ∼50% of infected human gut xenografts. Using species-specific CD31 immunostaining, we showed that iTMA was limited to the larger human-mouse chimeric blood vessels, which are located between the muscularis mucosa and circular muscular layer of the human gut. These blood vessels were massively invaded by bacteria, which adhered to and formed pedestals on endothelial cells and aggregated with mouse neutrophils in the lumen. We conclude that endothelial infection, iTMA, and ischemic enteritis might be central mechanisms underlying severe EPEC-mediated disease.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  EPEC; T3SS; human gut xenograft; mouse model; thrombotic microangiopathy

Year:  2017        PMID: 28784929      PMCID: PMC5649022          DOI: 10.1128/IAI.00558-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Authors:  Alexander R C Wong; Jaclyn S Pearson; Michael D Bright; Diana Munera; Keith S Robinson; Sau Fung Lee; Gad Frankel; Elizabeth L Hartland
Journal:  Mol Microbiol       Date:  2011-05-05       Impact factor: 3.501

2.  Fatal hemorrhage induced by subtilase cytotoxin from Shiga-toxigenic Escherichia coli.

Authors:  Takeshi Furukawa; Kinnosuke Yahiro; Atsushi B Tsuji; Yasuhiro Terasaki; Naoko Morinaga; Masaru Miyazaki; Yuh Fukuda; Tsuneo Saga; Joel Moss; Masatoshi Noda
Journal:  Microb Pathog       Date:  2011-01-11       Impact factor: 3.738

Review 3.  Enteropathogenic escherichia coli infection in children.

Authors:  Theresa J Ochoa; Carmen A Contreras
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

Review 4.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo.

Authors:  Yukiko Miyamoto; Mitsutoshi Iimura; James B Kaper; Alfredo G Torres; Martin F Kagnoff
Journal:  Cell Microbiol       Date:  2006-05       Impact factor: 3.715

Review 6.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

Review 7.  Necrotizing enterocolitis: the mystery goes on.

Authors:  Josef Neu
Journal:  Neonatology       Date:  2014-08-20       Impact factor: 4.035

8.  Beta-hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli.

Authors:  Navit Grinberg; Sharon Elazar; Ilan Rosenshine; Nahum Y Shpigel
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

9.  Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.

Authors:  M S Donnenberg; C O Tacket; S P James; G Losonsky; J P Nataro; S S Wasserman; J B Kaper; M M Levine
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Enterohemorrhagic Escherichia coli induce attaching and effacing lesions and hemorrhagic colitis in human and bovine intestinal xenograft models.

Authors:  Lilach Golan; Erez Gonen; Simcha Yagel; Ilan Rosenshine; Nahum Y Shpigel
Journal:  Dis Model Mech       Date:  2010-10-19       Impact factor: 5.758

View more
  7 in total

1.  Endothelial Caspase-8 prevents fatal necroptotic hemorrhage caused by commensal bacteria.

Authors:  Stefanie M Bader; Simon P Preston; Katie Saliba; Adam Lipszyc; Zoe L Grant; Liana Mackiewicz; Andrew Baldi; Anne Hempel; Michelle P Clark; Thanushi Peiris; William Clow; Jan Bjelic; Michael D Stutz; Philip Arandjelovic; Jack Teale; Fashuo Du; Leigh Coultas; James M Murphy; Cody C Allison; Marc Pellegrini; Andre L Samson
Journal:  Cell Death Differ       Date:  2022-07-23       Impact factor: 12.067

Review 2.  Animal Models of Type III Secretion System-Mediated Pathogenesis.

Authors:  Julia A Hotinger; Aaron E May
Journal:  Pathogens       Date:  2019-11-22

Review 3.  Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components.

Authors:  Julia A Hotinger; Heather A Pendergrass; Aaron E May
Journal:  Biomolecules       Date:  2021-02-19

4.  Genetic and antimicrobial resistance profiles of non-O157 Shiga toxin-producing Escherichia coli from different sources in Egypt.

Authors:  Mohamed Sabry Abd Elraheam Elsayed; Samah Mahmoud Eldsouky; Tamer Roshdy; Abeer Mohamed Ahmed Bayoume; Ghada M Nasr; Ali S A Salama; Behiry A Akl; Al Shaimaa Hasan; Amany Kasem Shahat; Rana Atef Khashaba; Walid Abdellatif Abdelhalim; Hend E Nasr; Lina Abdelhady Mohammed; Ahmed Salah
Journal:  BMC Microbiol       Date:  2021-09-23       Impact factor: 3.605

Review 5.  Evaluation of animal models of Crohn's disease with anal fistula (Review).

Authors:  Shuangshuang Lu; Keyuan Zhu; Yongxin Guo; Enjing Wang; Jin Huang
Journal:  Exp Ther Med       Date:  2021-07-08       Impact factor: 2.447

6.  Homeostasis of mucosal glial cells in human gut is independent of microbiota.

Authors:  Timna Inlender; Einat Nissim-Eliraz; Rhian Stavely; Ryo Hotta; Allan M Goldstein; Simcha Yagel; Michael J Gutnick; Nahum Y Shpigel
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

7.  The role of O-polysaccharide chain and complement resistance of Escherichia coli in mammary virulence.

Authors:  Hagit Salamon; Einat Nissim-Eliraz; Oded Ardronai; Israel Nissan; Nahum Y Shpigel
Journal:  Vet Res       Date:  2020-06-15       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.